This achievement is expected to enhance treatment accessibility for patients

Iran is set to introduce a groundbreaking anti-cancer vaccine in the summer of 2025, according to the institute established under the supervision of the Iranian Ministry of Science, Research and Technology.

This vaccine is designed to target various types of cancer, as reported by Mehr News Agency, a partner of TV BRICS. Institute representatives highlighted the success of domestic companies in advancing this technology, noting that they are currently capable of meeting 70 per cent of national demand.

Researchers of the institute also expressed confidence that these companies will soon be able to supply the country’s full requirements. This achievement is expected to significantly reduce reliance on imported medications and enhance treatment accessibility for patients.

The unveiling of the vaccine marks a new milestone in Iran’s medical and pharmaceutical sector, reinforcing efforts to develop innovative healthcare solutions through domestic research and technological advancements, as reported by the source.